Trump Pushes Reclassification Of Marijuana To Schedule III
Under the direction of Donald Trump, Acting Attorney General Todd Blanche signed an order moving state-licensed medical marijuana from Schedule I to Schedule III. It’s not legalization, not even close—but it’s the first time Washington has formally acknowledged what operators and patients have known for years: this isn’t heroin, and it never should’ve been treated like it.
The shift lands with quiet force. Schedule I was the industry’s original sin—no accepted medical use, high abuse potential, and a tax structure designed to bleed businesses dry. Moving to Schedule III changes that equation. Medical operators can now deduct standard business expenses, something previously blocked under IRS Code 280E. Rent, payroll, marketing—the basic mechanics of running a business—are back on the table. For a lot of operators, that’s the difference between survival and finally having room to breathe.
Implications For Hemp
Right now, hemp has lived in a strange loophole world built off the 2018 Farm Bill—as long as delta-9 THC stays under 0.3%, everything else slipped through. That’s how you got the explosion of delta-8, delta-10, and all the other converted products flooding gas stations and smoke shops. It wasn’t clean, it wasn’t consistent, but it was legal enough to scale.
This move toward Schedule III changes the tone at the federal level. When the government formally recognizes marijuana as having medical value and starts building regulated pathways around it, it becomes a lot harder to justify an unregulated parallel market selling psychoactive products with little oversight. You’re essentially watching two systems collide—one tightening up, the other about to get pulled into that gravity.
No More 280e?
Not immediately—but faster than most people expect if the rule holds.
Even though Todd Blanche signed the order, it still has to move through the formal rulemaking process (DEA publication, comment period if required, and final rule). Until that effective date hits, 280E is still in force.
New Investors
Schedule III lowers perceived risk, which makes lenders more comfortable first. Expect more debt options—regional banks, credit unions, structured financing—and gradually better rates as the stigma fades.
Equity follows slower. With 280E easing, financials start to look real, not distorted. That’s what institutional money needs—clean EBITDA, predictable returns, and a believable exit. That’s when valuations stabilize and M&A picks up.
This doesn’t lift everyone. Capital will concentrate around operators with clean books, compliance discipline, and scale potential.
